Upcoming New Protocols

Last Update 4/24/2008

Scheduled for IRB review May 9, 2008

Treatment

CTSU E1A06    Protocol  An Intergroup Phase III Randomized Controlled Trial Comparing Melphalan, Prednisone and Thalidomide Versus Melphalan, Prednisone and Lenalidomide in Newly Diagnosed Myeloma Patients Who Are Not Candidates for High-Dose Therapy

Cancer Control